Evidence map›Paper›PMID 41306084›Full record

ArticleChembiochem : a European journal of chemical biology2026

Exploring the Substitution of the C21-OAc Moiety in [11]Cytochalasans: Synthesis and Evaluation of Fluorophore Conjugates.

Mervic D Kagho, Katharina Schmidt, Aishi Chakrabarti, Marius Karger, Christopher Lambert, Maurice Hauser, Russell J Cox, Klemens Rottner, Marc Stadler, Theresia E Stradal and 1 more

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mervic D KaghoDepartment of Chemistry and Molecular Biology, Division of Organic and Medicinal Chemistry, University of Gothenburg, Natrium, Medicinaregatan 7B, 413 90, Gothenburg, Sweden.ORCID https://orcid.org/0000-0003-3714-7738
Katharina SchmidtDepartment of Cell Biology, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, D-38124, Braunschweig, Germany.ORCID https://orcid.org/0000-0003-1512-1748
Aishi ChakrabartiDepartment of Chemistry and Molecular Biology, Division of Organic and Medicinal Chemistry, University of Gothenburg, Natrium, Medicinaregatan 7B, 413 90, Gothenburg, Sweden.ORCID https://orcid.org/0009-0002-9704-0801
Marius KargerDepartment of Cell Biology, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, D-38124, Braunschweig, Germany.ORCID https://orcid.org/0009-0003-4513-3923
Christopher LambertDepartment of Cell Biology, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, D-38124, Braunschweig, Germany.ORCID https://orcid.org/0000-0002-1899-8214
Maurice HauserCentre of Biomolecular Drug Research (BMWZ), Institute for Organic Chemistry, Leibniz University Hannover, Schneiderberg 38., D- 30167, Hannover, Germany.ORCID https://orcid.org/0009-0003-0758-8521
Russell J CoxCentre of Biomolecular Drug Research (BMWZ), Institute for Organic Chemistry, Leibniz University Hannover, Schneiderberg 38., D- 30167, Hannover, Germany.ORCID https://orcid.org/0000-0002-1844-0157
Klemens RottnerDepartment of Cell Biology, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, D-38124, Braunschweig, Germany.ORCID https://orcid.org/0000-0003-4244-4198
Marc StadlerDepartment of Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, D-38124, Braunschweig, Germany.ORCID https://orcid.org/0000-0002-7284-8671
Theresia E StradalDepartment of Cell Biology, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, D-38124, Braunschweig, Germany.ORCID https://orcid.org/0000-0002-0352-9474
Philipp KlahnDepartment of Chemistry and Molecular Biology, Division of Organic and Medicinal Chemistry, University of Gothenburg, Natrium, Medicinaregatan 7B, 413 90, Gothenburg, Sweden.ORCID https://orcid.org/0000-0003-4713-2345

Funding

German Research Foundation CO 1328/10-1German Research Foundation KL 3012/4-1German Research Foundation RO 2414/12-1German Research Foundation STA 1282/8-1German Research Foundation STR 666/10-1University of starting funds
6 · The paper itself

Abstract

The actin cytoskeleton plays a central role in cellular organization and dynamics, yet the tools available for targeting actin function remain limited. Cytochalasans represent a large class of actin-targeting natural products that are readily cell permeable with varying cytotoxicity and actin-targeting capabilities in mammalian cells. Their pharmacologic exploitation not only requires an understanding of their mode of action but also exact knowledge of how they can be derivatized without affecting their bioactivity. Herein, the design, synthesis, and evaluation of five fluorescently labeled [11]cytochalasan derivatives generated from pyrichalasin H (PyriH) and 19,20-epoxycytochalasin C (EpoxyCytoC) are reported. Guided by molecular docking, the C21-OAc moiety is identified as a promising site for tag attachment without disrupting actin binding. Semisynthetic modifications enable the conjugation of different dyes to PyriH and EpoxyCytoC scaffolds. Moreover, the effect of linkers separating cytochalasans and dyes is analyzed. Biological evaluation supplemented by in vitro assays to additionally interrogates their activities on the assembly of pure actin filaments revealing distinct activity profiles. Together, this study compares permeability, cytotoxicity, and actin binding of five novel [11]cytochalasan probes bearing substitutions of the C21-OAc moiety. These findings establish the C21-OAc position as a versatile functionalization site and provide a framework for developing next generation cytochalasan-based actin-targeting probes.

Indexed as

CytochalasinsFluorescent DyesActinsHumansMolecular Docking SimulationMolecular StructureActinsCytochalasinsFluorescent Dyes[11]cytochalsansactin imagingmolecular dockingsemisynthesis

Identifiers

PMID41306084
PMCPMC12781145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.